Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Biolife Solutions Inc | 2 | 0 | 2 | 0 | €18.90 | €32.00 | 69.312% |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €71.50 | €100.00 | 39.860% |
| Purple Biotech Ltd. ADR | 5 | 0 | 1 | 0 | €0.49 | €9.21 | 1794.444% |
| Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €37.20 | €45.98 | 23.602% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €15.25 | €24.13 | 58.302% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Trinity Biotech ADR | 22 | 0 | 0 | 0 | €0.41 | - | - |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | €2.72 | €4.00 | 47.059% |
| Verastem Inc. | 10 | 0 | 1 | 0 | €11.10 | €24.63 | 121.935% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €1.76 | €4.16 | 136.836% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €96.11 | €116.81 | 21.535% |
| UCB S.A. | 2 | 0 | 0 | 0 | €120.50 | - | - |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | €27.96 | €35.99 | 28.703% |
| Dynavax Technologies Corp | 2 | 0 | 1 | 0 | €10.17 | €26.95 | 164.992% |
| GSK plc | 1 | 0 | 0 | 0 | €20.96 | - | - |
| Grifols S.A. | 1 | 0 | 0 | 0 | €10.03 | - | - |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €40.50 | €50.33 | 24.278% |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €121.70 | - | - |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €9.41 | - | - |
| PharmAust Ltd. | 1 | 0 | 0 | 0 | €0.087 | - | - |
| Adocia | 1 | 0 | 0 | 0 | €9.22 | €20.00 | 116.920% |
| Horizon Pharma plc | 6 | 0 | 0 | 0 | €110.40 | - | - |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €31.00 | €38.99 | 25.770% |
| Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €61.00 | €79.55 | 30.417% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.85 | - | - |